View in EDS

Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains

Saved in:
Bibliographic Details
Title: Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains
Authors: File, Thomas M.1 filet@summa-health.org, Garau, Javier2, Jacobs, Michael R.3, Wynne, Brian4, Twynholm, Monique5, Berkowitz, Elchonon4
Source: International Journal of Antimicrobial Agents. Feb2005, Vol. 25 Issue 2, p110-119. 10p.
Database: Environment Complete
Description
ISSN:09248579
DOI:10.1016/j.ijantimicag.2004.10.007